Approval · Notice of Compliance 33119 · 2024
LUVOX: Notice of Compliance 33119
Issued April 26, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33119
- Date
- April 26, 2024
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Adding an alternate drug substance manufacturer site. Adding a new source of starting material from the supplier.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUVOX | Not yet assigned | — |
Medicinal ingredients
- FLUVOXAMINE MALEATE 50 MG per TAB
- FLUVOXAMINE MALEATE 100 MG per TAB